Showing 161 - 180 results of 8,626 for search '(( significantly we decrease ) OR ( ((significantly lower) OR (significantly weaker)) decrease ))', query time: 0.49s Refine Results
  1. 161

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(B)</b> Early glycolytic intermediates and the ratio of F-6-P to F-1,6-BP (<i>lower right</i>) are shown. <b>(C)</b> Heatmap of targeted metabolomic data. …”
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173

    S1 Data - by Richard Junior Zapata Dongo (17912565)

    Published 2025
    “…This interaction was further supported by a significant decrease of ALK phosphorylation in single and combination treatment with 300nM ABT-199. …”
  14. 174

    Qualitative changes in the implant subgroup. by Adela Klezlova (22608008)

    Published 2025
    “…In the study group, the IOP was statistically significantly lower by 29% at the end of the follow-up compared to the preoperative measurements (<i><i>p</i></i> = 0.009). …”
  15. 175

    Results of the colorimetric MTT test. by Adela Klezlova (22608008)

    Published 2025
    “…In the study group, the IOP was statistically significantly lower by 29% at the end of the follow-up compared to the preoperative measurements (<i><i>p</i></i> = 0.009). …”
  16. 176

    IOP fluctuation. by Adela Klezlova (22608008)

    Published 2025
    “…In the study group, the IOP was statistically significantly lower by 29% at the end of the follow-up compared to the preoperative measurements (<i><i>p</i></i> = 0.009). …”
  17. 177

    IOP fluctuation. by Adela Klezlova (22608008)

    Published 2025
    “…In the study group, the IOP was statistically significantly lower by 29% at the end of the follow-up compared to the preoperative measurements (<i><i>p</i></i> = 0.009). …”
  18. 178

    Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

    Published 2025
    “…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”
  19. 179
  20. 180